MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 56 filers reported holding MEDIVATION INC in Q3 2016. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $6,492,000 | -60.5% | 107,656 | -69.9% | 0.03% | -65.2% |
Q1 2016 | $16,431,000 | +432.6% | 357,332 | +460.0% | 0.09% | +384.2% |
Q4 2015 | $3,085,000 | +140.5% | 63,813 | +111.5% | 0.02% | +137.5% |
Q3 2015 | $1,283,000 | +5.0% | 30,178 | +182.0% | 0.01% | +14.3% |
Q2 2015 | $1,222,000 | +16.5% | 10,703 | +31.8% | 0.01% | -12.5% |
Q1 2015 | $1,049,000 | +45.9% | 8,122 | +12.5% | 0.01% | +60.0% |
Q4 2014 | $719,000 | -87.7% | 7,222 | -87.8% | 0.01% | -91.7% |
Q3 2014 | $5,848,000 | +1716.1% | 59,146 | +1317.7% | 0.06% | +1400.0% |
Q2 2014 | $322,000 | – | 4,172 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |